Stryker Corp
F:SYK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Stryker Corp
F:SYK
|
US |
Intrinsic Value
The intrinsic value of 
Stryker Corp (SYK) under the Base Case is 283.16 EUR per share.
Compared with the current market price of 273.4 EUR, the stock appears
Undervalued by 3% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Stryker Does
Stryker makes medical devices and hospital equipment that help doctors treat injuries, replace damaged joints, and perform surgery. Its products include hip and knee implants, surgical tools, operating-room systems, trauma devices, and equipment used in emergency rooms and ambulances. It also sells products for neurovascular care, which are used in treating certain stroke and brain conditions.
- Headquarters
- United States of America US
- Employees
- 56 000
- IPO date
- Mar 17, 1980
Stryker has a wide economic moat
Replacing familiar surgical tools and procedures takes retraining and changes to hospital equipment, giving surgeons and hospitals practical reasons to stay with Stryker. Patents covering its implants and Mako robotic technology also prevent competitors from simply copying protected designs.
Read the full moat analysis
Revenue & Expenses Breakdown
Stryker Corp
Earnings Waterfall
Stryker Corp
The intrinsic value for Stryker Corp (SYK) under the Base Case is 283.16 EUR.
Compared with the current market price of 273.4 EUR, the stock appears Undervalued by 3% .